Literature DB >> 33790501

Does Presence of Sepsis by Itself Predispose the Patients to HCAIs?

Sheetal Gaikwad1, Vijaya P Patil1.   

Abstract

How to cite this article: Gaikwad S, Patil VP. Does Presence of Sepsis by Itself Predispose the Patients to HCAIs? Indian J Crit Care Med 2021;25(3):253-254.
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.

Entities:  

Keywords:  Health care-associated infection; Immunoparalysis; Outcome

Year:  2021        PMID: 33790501      PMCID: PMC7991764          DOI: 10.5005/jp-journals-10071-23771

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


Health care-associated infection (HCAI) is one of the most serious complications in critically ill patients as it leads to increase in ICU and hospital length of stay and increase in mortality. Medical literature is full of articles describing the risk of HCAIs in various patient populations. In this issue of IJCCM, Venkataraman et al. have tried to address the same.[1] Most of the studies have shown that there are multiple risk factors for developing HCAI and include old age (>65 years), emergency admission to ICU, duration of hospitalization before ICU admission, presence of indwelling devices, such as central line, endotracheal tube, and urinary catheters, prolonged and extensive surgery, trauma, neutropenia, and parenteral nutrition. Over and above these factors, the health care practices, trained personnel, basic hygiene, nurse–patient ratio also contribute to the development of HCAI.[2] Since these factors are common in the ICU population, whether critically ill patients have sepsis or not, there is no reason why the incidence of HCAI should be different. The main reason for the belief that HCAIs incidence is likely to be more in septic patients, is the belief that septic patients tend to develop immunoparalysis, in addition to the other factors mentioned above.[3,4] However, this is not entirely true, as immunoparalysis in a critically ill patient is a very complex and ill-understood phenomenon. Immunoparalysis is seen in critical illness and involves alterations in both innate and adaptive immune responses, including neutrophil dysfunction, altered monocyte phenotype and antigen presentation capacity, lymphopenia and impaired lymphocyte responses, and elevated pro-inflammatory cytokines. Immunoparalysis is the result of multiple factors and includes patient's genetic predisposition (predisposition to a compensatory anti-inflammatory response), which is a heritable trait.[5] It is also related to the degree of initial inflammation observed with a critical illness or injury, such as surgery, trauma, burns, or infection. Brain injury is also associated with immunoparalysis. In 1986, Polk et al. undertook a systematic study of host defense processes in badly injured patients. They studied 20 adults with severe trauma to correlate the immunologic factors associated with the development of secondary infection and late mortality. They found that persistent impairment in monocyte antigen-presenting capacity was associated with the development of nosocomial sepsis.[6] Many drugs, such as steroids, opioids, sedatives, catecholamines, and blood transfusion used in critically ill patients are known to contribute to immunoparalysis.[7,8] Device use is recognized as a high risk for device-associated nosocomial infections in ICU patients.[9,10] Though it is not a consistent finding, studies also suggest that a persistently high level of therapeutic activity and persistently depressed consciousness after ICU admission are associated with the acquisition of nosocomial infection by critically ill patients.[11] Thus, the risk of acquiring HCAI will depend on the immune status of the patient, intensity of interventions, and of course adherence to infection control practices. Hence, it makes sense to correlate the presence of immunoparalysis, presence of devices, degree of therapeutic activity, and mentation with HCAI rather than just whether the patient is septic or nonseptic.
  9 in total

1.  Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.

Authors:  Roeland F Stolk; Tom van der Poll; Derek C Angus; Johannes G van der Hoeven; Peter Pickkers; Matthijs Kox
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 2.  Immunoparalysis and adverse outcomes from critical illness.

Authors:  W Joshua Frazier; Mark W Hall
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

3.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

4.  Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients.

Authors:  E Girou; F Stephan; A Novara; M Safar; J Y Fagon
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.

Authors:  B Digiovine; C Chenoweth; C Watts; M Higgins
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

Review 6.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

7.  Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.

Authors:  Lonneke A van Vught; Peter M C Klein Klouwenberg; Cristian Spitoni; Brendon P Scicluna; Maryse A Wiewel; Janneke Horn; Marcus J Schultz; Peter Nürnberg; Marc J M Bonten; Olaf L Cremer; Tom van der Poll
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

8.  Bloodstream infections among patients using central venous catheters in intensive care units.

Authors:  Eni Rosa Aires Borba Mesiano; Edgar Merchán-Hamann
Journal:  Rev Lat Am Enfermagem       Date:  2007 May-Jun

9.  Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.

Authors:  Yves Le Tulzo; Celine Pangault; Laurence Amiot; Valérie Guilloux; Olivier Tribut; Cédric Arvieux; Christophe Camus; Renée Fauchet; Rémi Thomas; Bernard Drénou
Journal:  Am J Respir Crit Care Med       Date:  2004-03-17       Impact factor: 21.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.